Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Activated T lymphocyte
BIOLOGICAL
2 trials
Sponsors
GC Cell Corporation
, Seoul National University Hospital
Conditions
Neuroblastoma
Pancreatic Cancer
Phase 2
Evaluate the Efficacy and Safety of Activated T-lymphocyte Cell Therapy in Advanced Pancreatic Cancer
Completed
NCT00965718
GC Cell Corporation
Pancreatic Cancer
Start: 2009-09-30
End: 2010-12-31
Updated: 2023-07-19
Unknown Phase
A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma
Completed
NCT01802138
Seoul National University Hospital
Neuroblastoma
Start: 2013-02-28
End: 2018-10-31
Target: 6
Updated: 2019-04-09
Related Papers
Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer
Cancer Immunology Immunotherapy
2014-06-11
79 citations